Cutaneous Immunization Rapidly Activates Liver Invariant Vα14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity

Journal of Experimental Medicine

Volumn 198, Issue 12, 2003, Pages 1785-1796

  Campos, Regis A ^a,c,d   Szczepanik, Marian ^b   Itakura, Atsuko ^a   Akahira Azuma, Moe ^a   Sidobre, Stephane ^d   Kronenberg, Mitchell ^d   Askenase, Philip W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

B 1 cells; Contact sensitivity; IL 4; Liver lymphocytes; V 14i NKT cells

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; TETRAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL TRANSFER; COMPLEMENT ACTIVATION; CONTACT SENSITIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; B-LYMPHOCYTES; DERMATITIS, CONTACT; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN M; INTERLEUKIN-4; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0347911963     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021562     Document Type: Article

References (50)

1. Van Loveren, H., and P.W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133:2397-2401.
2. Tsuji, R.F., M. Szczepanik, I. Kawikova, V. Paliwal, R.A. Campos, M. Akahira-Azuma, N. Baumgarth, L.A. Herzenberg, and P.W. Askenase. 2002. B-cell dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196:1277-1290.
3. Tsuji, R.F., I. Kawikova, R. Ramabhadran, M. Akahira-Azuma, D. Taub, T.E. Hugli, C. Gerard, and P.W. Askenase. 2000. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165:1588-1598.
4. Askenase, P.W., S. Bursztajn, M.D. Gershon, and R.K. Gershon. 1980. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152:1358-1374.
5. Kops, S.K., H. Van Loveren, R.W. Rosenstein, W. Ptak, and P.W. Askenase. 1984. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor. Lab. Invest. 50:421-434.
6. Geba, G.P., W. Ptak, G.M. Anderson, V. Paliwal, R.E. Ratzlaff, J. Levin, and P.W. Askenase. 1996. Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. J. Immunol. 157:557-505.
7. Matsuda, H., H. Ushio, G.P. Geba, and P.W. Askenase. 1997. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J. Immunol. 158:2891-2897.
8. McHale, J.F., O.A. Harari, D. Marshall, and D.O. Haskard. 1999. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-α. J. Immunol. 162:1648-1655.
9. Schwartz, A., P.W. Askenase, and R.K. Gershon. 1977. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J. Immunol. 118:159-165.
10. Gershon, R.K., P.W. Askenase, and M.D. Gershon. 1975. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J. Exp. Med. 142:732-747.
11. Askenase, P.W. 2001. Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin. Exp. Immunol. 125:345-350.
12. Godfrey, D.I., K.J.L. Hammond, L.D. Poulton, M.J. Smyth, and A.G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today. 21:573-583.
13. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
14. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
15. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1626-1629.
16. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 38:2176-2187.
17. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
18. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
19. Erickson, L.D., T.M. Foy, and T.J. Waldschmidt. 2001. Murine B1 B cells require IL-5 for optimal T cell-dependent activation. J. Immunol. 166:1531-1539.
20. Van Loveren, H., K. Kato, R. Meade, D.R. Green, M. Horowitz, W. Ptak, and P.W. Askenase. 1984. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 133:2402-2411.
21. Ptak, W., W.R. Herzog, and P.W. Askenase. 1991. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J. Immunol. 146:469-475.
22. Ptak, W., G.P. Geba, and P.W. Askenase. 1991. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J. Immunol. 146:3929-3936.
23. Tsuji, R.F., G.P. Geba, Y. Wang, K. Kawamoto, L.A. Matis, and P.W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ: a possible initiating role of B cells. J. Exp. Med. 186:1015-1026.
24. Askenase, P.W., H. Van Loveren, S. Kraeuter-Kops, Y. Ron, R. Meade, T.C. Theoharides, J.J. Nordlund, H. Scovern, M.D. Gerhson, and W. Ptak. 1983. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol. 131:2687-2694.
25. van Loveren, H., R. Meade, and P.W. Askenase. 1983. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157:1604-1617.
26. Yoshimoto, T., and W.E. Paul. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
27. Chen, H., and W.E. Paul. 1997. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 of CD1. J. Immunol. 159:2240-2249.
28. Kitamura, H., A. Ohta, M. Sekimoto, M. Sato, K. Iwakabe, M. Nakui, T. Yahata, H. Meng, T. Koda, S. Nishimura, et al. 2000. α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199:37-42.
29. Pior, J., T. Vogl, C. Sorg, and E. MacHer. 1999. Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113:888-893.
30. Ishii, N., K. Takahashi, H. Nakajima, S. Tanaka, and P.W. Askenase. 1994. DNFB contact sensitivity (CS) in BALB/c and C3H/He mice: requirement for early-occurring, early-acting, antigen-specific, CS-initiating cells with an unusual phenotype (Thy-1+, CD5+, CD3-, CD4-, CD8-, sIg-, B220+, MHC class II-, CD23+, IL-2N-, IL-3R+, Mel-14-, Pgp-1+, J11d+, MAC-1+, LFA-1+, and Fc γ RII+). J. Invest. Dermatol. 102:321-327.
31. Ishii, N., Y. Sugita, H. Nakajima, S. Tanaka, and P.W. Askenase. 1995. Elicitation of nickel sulfate (NiSO4)-specific delayed-type hypersensitivity requires early-occurring and early-acting, NiSO4- specific DTH-initiating cells with an unusual mixed phenotype for an antigen-specific cell. Cell. Immunol. 161:244-255.
32. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells reduces the differentiation of antigen specific cytotoxic T lymphocytes. Int. Immunol. 12:987-994.
33. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu. 2003. Essential role of NK cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582-588.
34. Lisbonne, M., S. Diem, A.C. Keller, J. Lefort, L.M. Araujo, P. Hachem, J. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:1637-1641
35. + T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197:997-1005.
36. Galli, G., S. Nutti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani. 2003. CD1d-restricted help To B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197:1051-1057.
37. Leite-de Moraes, M.C., A. Herbelin, C. Gouarin, Y. Koezuka, E. Schneider, and M. Dy. 2000. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 165:4367-4371.
38. Osman, Y., T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, K. Okumura, and T. Abo. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 30:1919-1928.
39. Eberl, G., and H.R. MacDonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3epsilon- of IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity. 9:345-353.
40. Singh, A.K., M.T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A.K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801-1811.
41. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 413:531-534.
42. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA. 97:8461-8466.
43. Exley, M.A., N.J. Bigley, O. Cheng, S.M. Tahir, S.T. Smiley, Q.L. Carter, H.F. Stills, M.J. Grusby, Y. Koezuka, M. Taniguchi, and S.P. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69:713-718.
44. Ishikawa, H., H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, et al. 2000. CD4(+) V(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:1267-1274.
45. Kumar, H., A. Belperron, S.W. Barthold, and L.K. Bockenstedt. 2000. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165:4797-4801.
46. Kakimi, K., L.G. Guidotti, Y. Koezuka, and F.V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921-930.
47. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA. 97:6498-5503.
48. Nakagawa, N., I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, K. Iijima, K. Motoki, M. Kamishohara, and S. Seki. 2001. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J. Immunol. 166:6578-6584.
49. van der Vliet, H.J., B.M. von Blomberg, N. Nishi, M. Reijm, A.E. Voskuyl, A.A. van Bodegraven, C.H. Polman, T. Rustemeyer, P. Lips, A.J. van den Eertwegh, et al. 2001. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:144-148.
50. Biron, C.A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458-464.